Sedzik Jan, Carlone Giulia, Fasano Anna, Liuzzi Grazia Maria, Riccio Paolo
Department of Biochemistry and Molecular Biology, Bari University, Bari, Italy.
J Struct Biol. 2003 May;142(2):292-300. doi: 10.1016/s1047-8477(03)00031-5.
The P2 protein of peripheral nervous system myelin induces experimental allergic neuritis in rats, a model of Guillain-Barré syndrome in humans. Previous purification procedures have used acid extraction to obtain the protein in lipid-free form (LF-P2). Here, we have purified the P2 protein in lipid-bound form (LB-P2) by extracting myelin with the detergent CHAPS, followed by Cu(2+)-affinity column chromatography. All myelin lipids were present in the preparation as shown by high-performance thin-layer chromatography and mass spectrometry. The LB-P2 preparation, which differs from LF-P2 in solubility and in the secondary-structure composition, was dialyzed to remove unbound lipids and excess detergent and crystallized using the hanging-drop vapor diffusion technique. Crystals of lipid-bound P2 appeared usually very reproducibly within 2 weeks at pH 5.7 in polyethylene glycol 6000 (PEG6000) at concentrations of 20-30% (w/v), and larger crystals were obtained by additional sitting-drop crystallization. X-ray diffraction showed reflections up to 2.7A. The crystallization conditions (25-30% PEG6000, pH 5.0) and the unit cell dimensions (a = 94.5A, b = 94.5A, c=74.2A, alpha = beta = 90 degrees, gamma = 120 degrees ) of LB-P2 were different from those earlier described for LF-P2 (10% PEG4000, pH 3, and unit cell dimensions a = 91.8A, b = 99.5A, c = 56.5A, alpha = beta = gamma = 90.0 degrees ). It is important that P2 has been crystallized with specifically bound lipids; therefore, solving this new crystal structure will reveal details of this protein's behavior and role in the myelin sheath.
外周神经系统髓磷脂的P2蛋白可诱发大鼠实验性变应性神经炎,这是人类吉兰-巴雷综合征的一种模型。以往的纯化程序采用酸提取法以获得无脂形式的蛋白(LF-P2)。在此,我们通过用去污剂CHAPS提取髓磷脂,随后进行铜(2+)亲和柱层析,纯化出了脂结合形式的P2蛋白(LB-P2)。高效薄层色谱和质谱分析表明,制备物中存在所有的髓磷脂脂质。LB-P2制剂在溶解度和二级结构组成方面与LF-P2不同,经透析去除未结合的脂质和过量的去污剂,并用悬滴气相扩散技术进行结晶。脂结合P2的晶体通常在2周内于pH 5.7、浓度为20 - 30%(w/v)的聚乙二醇6000(PEG6000)中非常可重复地出现,通过额外的坐滴结晶可获得更大的晶体。X射线衍射显示反射峰高达2.7埃。LB-P2的结晶条件(25 - 30% PEG6000,pH 5.0)和晶胞尺寸(a = 94.5埃,b = 94.5埃,c = 74.2埃,α = β = 90度,γ = 120度)与先前描述的LF-P2(10% PEG4000,pH 3,晶胞尺寸a = 91.8埃,b = 99.5埃,c = 56.5埃,α = β = γ = 90.0度)不同。重要的是,P2已与特异性结合的脂质一起结晶;因此,解析这种新的晶体结构将揭示该蛋白在髓鞘中的行为和作用细节。